Showing results (661-670 of 759) with videos related to

Sort By:
Pageof 76
JAMA Cardiology|July 27, 2018
Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac AmyloidosisKevin M Alexander, John Orav, Avinainder Singh, et al.
Journal of Immunology Research|October 30, 2023
Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood NeutrophilsEugene R Bleecker, Reynold A Panettieri, Njira L Lugogo, et al.
Annals of Neurology|February 10, 2023
Cerebral Small Vessel Disease Progression Increases Risk of Incident ParkinsonismMina A Jacob, Mengfei Cai, Mayra Bergkamp, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 29, 2024
Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE)Jorge F Maspero, Martti A Antila, Antoine Deschildre, et al.
American Journal of Rhinology & Allergy|September 20, 2024
Association Between Smell Loss, Disease Burden, and Dupilumab Efficacy in Chronic Rhinosinusitis with Nasal PolypsZachary M Soler, Zara M Patel, Joaquim Mullol, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 18, 2026
Dupilumab Efficacy in Children With Uncontrolled, Moderate-to-Severe, Type 2 Asthma by Allergen Sensitization LevelWanda Phipatanakul, Nikolaos G Papadopoulos, Vivian Hernandez-Trujillo, et al.
American Journal of Respiratory and Critical Care Medicine|February 12, 2025
Current Smoker: A Clinical COPD Phenotype Affecting Disease Progression and Response to TherapyBartolome R Celli, Stephanie Christenson, Klaus F Rabe, et al.
The Journal of Allergy and Clinical Immunology|November 16, 2025
Transient early blood eosinophil increases do not affect dupilumab's long-term efficacy in patients with moderate-to-severe asthmaIan D Pavord, Njira L Lugogo, Mario Castro, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1982
The metabolism of avermectins B1a, H2B1a, and H2B1b by liver microsomesG T Miwa, J S Walsh, W J VandenHeuvel, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 6, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthmaWilliam W Busse, Monica Kraft, Christian Domingo, et al.
Pageof 76